Cedazuridine

Chemical Information
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as [decitabine] and [azacitidine] are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous cells. Although effective, these compounds are rapidly metabolized by cytidine deaminase (CDA) prior to reaching systemic circulation when administered orally, necessitating intramuscular or intravenous administration routes. Cedazuridine is a fluorinated tetrahydrouridine derivative specifically designed to inhibit CDA and facilitate oral administration of hypomethylating agents. Cedazuridine was first reported in 2014, and was subsequently approved by the FDA on July 7, 2020, in combination with [decitabine] for sale by Astex Pharmaceuticals Inc under the name INQOVI®.
| CAS Number | 1141397-80-9 |
| PubChem CID | 25267009 |
| IUPAC Name | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.21 |
| XLogP | -1.1 |
| Topological Polar Surface Area | 102 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Property | Value |
|---|---|
| Molecular Weight | 268.21 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08707788 |
| Monoisotopic Mass | 268.08707788 |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Alternative Products
Popular Products

SequaGel MD Monomer Solution
SKU: EC-845|Size: 200 mL

West Nile Virus - Envelope protein
SKU: REC31614-100|Size: 1 Each

Yellow Fever Virus- NS1
SKU: YFV-NS1-100|Size: 1 Each

Dengue Virus Serotype 4 NS1 Protein (HEK293)
SKU: DENV4-NS1-100|Size: 1 Each

West Nile Virus -NS1
SKU: WNV-NS1-100|Size: 1 Each

Tick-Borne Encephalitis Virus NS1
SKU: TBEV-NS1-100|Size: 1 Each

Glucose M9Y
SKU: 0108|Size: 500 g

Human Inositol-3-phosphate synthase 1, ISYNA1 ELISA Kit
SKU: MBS9340649-01|Size: 48 Well

Carboxyl Polystyrene Particles, 5% w/v, 4.0-4.4 µm
SKU: CP-40-10|Size: 10 mL

PhaseShield™ Gel Tubes, Light (50x 2ml)
SKU: M2302-05L|Size: 50x 2 mL

Human Insulin Like Growth Factor Binding Protein 7 (IGFBP7) ELISA Kit
SKU: RDR-IGFBP7-Hu-01|Size: 96 Tests

Mouse Insulin Like Growth Factor 1 (IGF1) ELISA Kit
SKU: RD-IGF1-Mu-01|Size: 96 Tests

Human Insulin Like Growth Factor Binding Protein, Acid Labile Subunit (IGFALS) ELISA Kit
SKU: RDR-IGFALS-Hu-01|Size: 96 Tests

Sheep Insulin Like Growth Factor 1 (IGF1) ELISA Kit
SKU: RDR-IGF1-Sh-01|Size: 96 Tests

Mouse Insulin Like Growth Factor Binding Protein 7 (IGFBP7) ELISA Kit
SKU: RDR-IGFBP7-Mu-01|Size: 96 Tests

Bovine Insulin Like Growth Factor Binding Protein 1 (IGFBP1) ELISA Kit
SKU: RD-IGFBP1-b-01|Size: 96 Tests

Human Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) ELISA Kit
SKU: RD-IGF2BP3-Hu-01|Size: 96 Tests

Mouse Insulin Like Growth Factor Binding Protein 6 (IGFBP6) ELISA Kit
SKU: RD-IGFBP6-Mu-01|Size: 96 Tests

Human Insulin Like Growth Factor Binding Protein 1 (IGFBP1) ELISA Kit
SKU: RD-IGFBP1-Hu-01|Size: 96 Tests

Mouse Insulin Like Growth Factor 2 MRNA Binding Protein 3 (IGF2BP3) ELISA Kit
SKU: RDR-IGF2BP3-Mu-01|Size: 48 Tests
